In a murine xenograft model of lung cancer, endostatin treatment led to a reduction in the number of M2 - like TAMs and Tie - 2 - expressing monocytes (TEMs) in the tumors, while the number of M1 - like TAMs showed an increase, although not statistically significant. This evidence concerns the gene COL18A1 and lung carcinoma.